Brief: Anika Reports Q4 And Year-End Fiscal 2022 Financial Results

Anika Therapeutics

06/03/2023 23:44

March 6 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS FOURTH QUARTER AND YEAR-END FISCAL 2022
FINANCIAL
RESULTS
    * EXPECTS ITS OVERALL REVENUE FOR FISCAL YEAR 2023 TO BE
BETWEEN
$158 MILLION AND $163 MILLION
    * QTRLY LOSS PER SHARE $0.34
    * Q4 EARNINGS PER SHARE VIEW $-0.24, REVENUE VIEW $37.7
MILLION --
REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $168.4 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX39tLZ1 
Further company coverage:  ANIK.O 

 ((Reuters.Briefs@thomsonreuters.com;))